Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI


Primary Symbol: V.BTI.H Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by jdstoxon Oct 18, 2018 1:08pm
123 Views
Post# 28828451

RBC

RBCA client of RBC is having fun. Here's the market depth from a few minutes ago:

Canaccord 1500 shares at $0.330
RBC 500 shares at $0.350
RBC 500 shares at $0.355
RBC 500 shares at $0.360
RBC 500 shares at $0.365
RBC 500 shares at $0.370
RBC 500 shares at $0.375
BMO 6500 shares at $0.375
Anonymous 5000 shares $0.380
Canaccord 1500 shares $0.380

That's it! Six RBC offers, all 500 shares, all in a row, all sequential at $.005 intervals.

Clearly, they don't want people without market depth (Level 2) to think this might gap up.

Without these RBC "offers" the lowest two offers would be 35¢ and 37.5¢. They're doing a similar thing on the bids, with a box created from the high 20s to mid 30s. And all these bids/offers slide up and down with the share price.

These RBC shenanigans have been going on for at least 2 or 3 weeks.

I wonder...

jdstox
 
Bullboard Posts